Frequency and Manifestations of Autoimmunity Among Children Registered in the Kuwait National Primary Immunodeficiency Registry

Michel J Massaad 1 2, Mohammad Zainal 3, Waleed Al-Herz 4 5

Affiliations

02 June 2020

-

doi: 10.3389/fimmu.2020.01119

Abstract

Objectives: To present a prospective report on the characteristics of autoimmune manifestations in patients with primary immunodeficient children registered in the Kuwait National PIDs Registry (KNPIDR). Methods: The data were obtained from the Kuwait National Primary Immunodeficiency Disorders Registry during the period of January 2004 to December 2019. Results: A total of 286 PID children were registered in KNPIDR during the study period with a predominance of immunodeficiencies affecting cellular and humoral immunity followed by combined immunodeficiencies with associated syndromic features and diseases of immune dysregulation. Fifty-seven (19.9%) patients presented with a total of 107 autoimmune manifestations. There was no significant statistical association between autoimmune manifestations and gender. Patients with autoimmune manifestations were older at onset of PID symptoms compared to those with no such manifestations, but this did not reach level of significance. The diagnosis delay was longer in patients with autoimmune manifestations compared to those with no such manifestations (p = 0.038). Forty-seven percent of these manifestations were among the presenting symptoms while 53% were documented later during the course of the disease. Fifty-seven percent of the patients developed 1 autoimmune manifestation, 30% developed 2 such manifestations, and 16% had ≥3 autoimmune manifestations. The most common autoimmune manifestation was cytopenia, followed by gastrointestinal manifestations and manifestations of the skin, hair, and nails. Autoimmune cytopenia were more common in patients with immune dysregulation syndromes, while gastrointestinal and skin manifestations predominate in patients with immunodeficiencies affecting cellular and humoral immunity and endocrine manifestations were more common in immune dysregulation syndromes. There were significant statistical associations between developing autoimmune manifestations and death as well as PID categories, being more common in patients with immune dysregulation. The frequency of autoimmunity was high among patients with RAG, WAS, STAT5b, NF-κB2, Fas, FasL, LRBA, APECED, IL-10, and C4 deficiencies. Conclusions: Autoimmunity is frequent in patients with PIDs in Kuwait. This should prompt the suspicion of a PID in patients who present initially with autoimmunity, especially autoimmune cytopenia. Such patients should be managed with extra care since they are at a higher risk of death.

Keywords: autoimmunity; epidemiology; immune dysregulation; manifestations; mortality; primary immunodeficiencies; registry.

Similar articles

Spectrum of Viral Infections Among Primary Immunodeficient Children: Report From a National Registry.

Al-Herz W, Essa S.Front Immunol. 2019 May 29;10:1231. doi: 10.3389/fimmu.2019.01231. eCollection 2019.PMID: 31191561 Free PMC article.

Diagnostic and Predictive Contribution of Autoantibodies Screening in a Large Series of Patients With Primary Immunodeficiencies.

Tahiat A, Yagoubi A, Ladj MS, Belbouab R, Aggoune S, Atek L, Bouziane D, Melzi S, Boubidi C, Drali W, Bendahmane C, Iguerguesdaoune H, Taguemount S, Soufane A, Oukil A, Ketfi A, Messaoudi H, Boukhenfouf N, Ifri MA, Bencharif Madani T, Belhadj H, Benhala KN, Khiari M, Cherif N, Smati L, Arada Z, Zeroual Z, Bouzerar Z, Ibsaine O, Maouche H, Boukari R, Djenouhat K.Front Immunol. 2021 Apr 1;12:665322. doi: 10.3389/fimmu.2021.665322. eCollection 2021.PMID: 33868317 Free PMC article.

The Kuwait National Primary Immunodeficiency Registry 2004-2018.

Al-Herz W, Al-Ahmad M, Al-Khabaz A, Husain A, Sadek A, Othman Y.Front Immunol. 2019 Jul 24;10:1754. doi: 10.3389/fimmu.2019.01754. eCollection 2019.PMID: 31396239 Free PMC article. Clinical Trial.

Autoimmune and inflammatory manifestations in pediatric patients with primary immunodeficiencies and their importance as a warning sign.

Kaplan MY, Ozen S, Akcal O, Gulez N, Genel F.Allergol Immunopathol (Madr). 2020 Nov-Dec;48(6):701-710. doi: 10.1016/j.aller.2020.02.009. Epub 2020 May 20.PMID: 32446782

Rheumatologic and autoimmune manifestations in primary immune deficiency.

Kitcharoensakkul M, Cooper MA.Curr Opin Allergy Clin Immunol. 2019 Dec;19(6):545-552. doi: 10.1097/ACI.0000000000000583.PMID: 31425194 Review.

Cited by

Organ-based clues for diagnosis of inborn errors of immunity: A practical guide for clinicians.

Mohammadi F, Yadegar A, Mardani M, Ayati A, Abolhassani H, Rezaei N.Immun Inflamm Dis. 2023 Apr;11(4):e833. doi: 10.1002/iid3.833.PMID: 37102642 Free PMC article. Review.

The Autoimmune Manifestations in Patients with Genetic Defects in the B Cell Development and Differentiation Stages.

Azizi G, Hesari MF, Sharifinejad N, Fayyaz F, Chavoshzadeh Z, Mahdaviani SA, Alan MS, Jamee M, Tavakol M, Sadri H, Shahrestanaki E, Nabavi M, Ebrahimi SS, Shirkani A, Vosughi Motlagh A, Delavari S, Rasouli SE, Esmaeili M, Salami F, Yazdani R, Rezaei N, Abolhassani H.J Clin Immunol. 2023 May;43(4):819-834. doi: 10.1007/s10875-023-01442-6. Epub 2023 Feb 15.PMID: 36790564 Free PMC article.

Immune Dysregulation in Monogenic Inborn Errors of Immunity in Oman: Over A Decade of Experience From a Single Tertiary Center.

Al Farsi T, Ahmed K, Alshekaili J, Al Kindi M, Cook M, Al-Hosni A, Ansari Z, Nasr I, Al Sukaiti N.Front Immunol. 2022 Apr 6;13:849694. doi: 10.3389/fimmu.2022.849694. eCollection 2022.PMID: 35464432 Free PMC article.

Diagnosis and Treatment of a Patient With Severe Combined Immunodeficiency Due to a Novel Homozygous Mutation in the IL-7Rα Chain.

Mansour R, Bsat YE, Fadel A, El-Orfali Y, Noun D, Tarek N, Kabbara N, Abboud M, Massaad MJ.Front Immunol. 2022 Mar 28;13:867837. doi: 10.3389/fimmu.2022.867837. eCollection 2022.PMID: 35418989 Free PMC article.

The Primary Immunodeficiency Database in Japan.

Mitsui-Sekinaka K, Sekinaka Y, Endo A, Imai K, Nonoyama S.Front Immunol. 2022 Jan 10;12:805766. doi: 10.3389/fimmu.2021.805766. eCollection 2021.PMID: 35082792 Free PMC article. Review.

References

  1.  
    1. Tangye SG, Al-Herz W, Bousfiha A, Chatila T, Cunningham-Rundles C, Etzioni A, et al. Human inborn errors of immunity: 2019 update on the classification from the International Union of Immunological Societies Expert Committee. J Clin Immunol. (2020) 40:24–64. 10.1007/s10875-019-00737-x - DOI - PMC - PubMed
  2.  
    1. Goyal R, Bulua A, Nikolov N, Schwartzberg P, Siegel R. Rheumatologic and autoimmune manifestations of primary immunodeficiency disorders. Curr Opin Rheumatol. (2009) 21:78–84. 10.1097/BOR.0b013e32831cb939 - DOI - PMC - PubMed
  3.  
    1. Kolhatkar NS, Brahmandam A, Thouvenel CD, Becker-Herman S, Jacobs HM, Schwartz MA, et al. . Altered BCR and TLR signals promote enhanced positive selection of autoreactive transitional B cells in Wiskott-Aldrich syndrome. J Exp Med. (2015) 212:1663–77. 10.1084/jem.20150585 - DOI - PMC - PubMed
  4.  
    1. Magnani A, Brosselin P, Beaute J, de Vergnes N, Mouy R, Debre M, et al. . Inflammatory manifestations in a single-center cohort of patients with chronic granulomatous disease. J Allergy Clin Immunol. (2014) 134:655–62. 10.1016/j.jaci.2014.04.014 - DOI - PubMed
  5.  
    1. Hoyt K, Chatila T, Notarangelo L, Hazen M, Janssen E, Henderson L. The immunologic features of patients with early-onset and polyautoimmunity. Clin Immunol. (2020) 211:108326. 10.1016/j.clim.2019.108326 - DOI - PMC - PubMed
  6.  
    1. Fischer A, Provot J, Jais J. Autoimmune inflammatory manifestations occur frequently in patients with primary immunodeficiencies. J. Allergy Clin. Immunol. (2017) 140:1388–393. - PubMed
  7.  
    1. Grimbacher B, Warnatz K, Yong P, Korganow A, Peter H. The crossroads of autoimmunity and immunodeficiency: lessons from polygenic traits and monogenic defects. J Allergy Clin Immunol. (2016) 37:3–17. 10.1016/j.jaci.2015.11.004 - DOI - PubMed
  8.  
    1. Wakeland E, Liu K, Graham R. Delineating the genetic basis of systemic lupus erythematosus. Immunity. (2001) 15:397–408. 10.1016/S1074-7613(01)00201-1 - DOI - PubMed
  9.  
    1. Okada Y, Wu D, Trynka G, Raj T, Terao C, Ikari K, et al. . Genetics of rheumatoid arthritis contributes to biology and drug discovery. Nature. (2014) 506:376–81. 10.1038/nature12873 - DOI - PMC - PubMed
  10.  
    1. Bousfiha AA, Jeddane L, Ailal F, Benhsaien I, Mahlaoui N, Casanova JL, et al. . Primary immunodeficiency diseases worldwide: more common than generally thought. J Clin Immunol. (2013) 33:1–7. 10.1007/s10875-012-9751-7 - DOI - PubMed
  11.  
    1. Mahlaoui N, Jais JP, Brosselin P, Mignot C, Beaurain B, Brito C, et al. . Prevalence of primary immunodeficiencies in France is underestimated. J Allergy Clin Immunol. (2017) 40:1731–3. 10.1016/j.jaci.2017.06.020 - DOI - PubMed
  12.  
    1. Al-Herz W, Aldhekri H, Barbouche M, Rezaei N. Consanguinity and primary immunodeficiencies. Hum Hered. (2014) 77:138–43. 10.1159/000357710 - DOI - PubMed
  13.  
    1. Hadizadeh H, Salehi M, Khoramnejad S, Vosoughi K, Rezaei N. The association between parental consanguinity and primary immunodeficiency diseases: a systematic review and meta-analysis. Pediatr Allergy Immunol. (2017) 28:280–7. 10.1111/pai.12685 - DOI - PubMed
  14.  
    1. Al-Herz W, Al-Ahmad M, Al-Khabaz A, Husain A, Sadek A, Othman Y. The Kuwait national primary immunodeficiency registry 2004-2018. Front Immunol. (2019) 10:1754 10.3389/fimmu.2019.01754 - DOI - PMC - PubMed
  15.  
    1. Seidel MG, Kindle G, Gathmann B, Quinti I, Buckland M, van Montfrans J, et al. . The European society for immunodeficiencies (ESID) registry working definitions for the clinical diagnosis of inborn errors of immunity. J Allergy Clin Immunol Pract. (2019) 7:1763–70. 10.1016/j.jaip.2019.02.004 - DOI - PubMed
  16.  
    1. Al-Tamemi S, Naseem SU, Al-Siyabi N, El-Nour I, Al-Rawas A, Dennison D, et al. . Primary immunodeficiency diseases in Oman: 10-year experience in a tertiary care hospital. J Clin Immunol. (2016) 36:785–92. 10.1007/s10875-016-0337-7 - DOI - PubMed
  17.  
    1. Errante PR, Franco JL, Espinosa-Rosales FJ, Sorensen R, Condino-Neto A. Advances in primary immunodeficiency diseases in Latin America: epidemiology, research, and perspectives. Ann N Y Acad Sci. (2012) 1250:62–72. 10.1111/j.1749-6632.2011.06289.x - DOI - PubMed
  18.  
    1. Gathmann B, Goldacker S, Klima M, Belohradsky BH, Notheis G, Ehl S, et al. . The German national registry for primary immunodeficiencies (PID). Clin Exp Immunol. (2013) 173:372–80. 10.1111/cei.12105 - DOI - PMC - PubMed
  19.  
    1. Ishimura M, Takada H, Doi T, Imai K, Sasahara Y, Kanegane H, et al. . Nationwide survey of patients with primary immunodeficiency diseases in Japan. J Clin Immunol. (2011) 31:968–76. 10.1007/s10875-011-9594-7 - DOI - PubMed
  20.  
    1. Kirkpatrick P, Riminton S. Primary immunodeficiency diseases in Australia and New Zealand. J Clin Immunol. (2007) 27:517–24. 10.1007/s10875-007-9105-z - DOI - PubMed
  21.  
    1. Stray-Pedersen A, Abrahamsen TG, Froland SS. Primary immunodeficiency diseases in Norway. J Clin Immunol. (2000) 20:477–85. 10.1023/A:1026416017763 - DOI - PubMed
  22.  
    1. Mellouli F, Mustapha IB, Khaled MB, Besbes H, Ouederni M, Mekki N, et al. . Report of the Tunisian Registry of primary immunodeficiencies: 25-years of experience (1988-2012). J Clin Immunol. (2015) 35:745–53. 10.1007/s10875-015-0206-9 - DOI - PubMed
  23.  
    1. Bousfiha AA, Jeddane L, El Hafidi N, Benajiba N, Rada N, El Bakkouri J, et al. . First report on the Moroccan registry of primary immunodeficiencies: 15 years of experience (1998-2012). J Clin Immunol. (2014) 34:459–68. 10.1007/s10875-014-0005-8 - DOI - PubMed
  24.  
    1. Shillitoe B, Bangs C, Guzman D, Gennery AR, Longhurst HJ, Slatter M, et al. . The United Kingdom Primary Immune Deficiency (UKPID) registry 2012 to 2017. Clin Exp Immunol. (2018) 192:284–91. 10.1111/cei.13125 - DOI - PMC - PubMed
  25.  
    1. Ehlayel M, Bener A, Laban M. Primary immunodeficiency diseases in children: 15 year experience in a tertiary care medical center in Qatar. J Clin Immunol. (2013) 33:317–24. 10.1007/s10875-012-9812-y - DOI - PubMed
  26.  
    1. Abolhassani H, Kiaee F, Tavakol M, Chavoshzadeh Z, Mahdaviani SA, Momen T, et al. . Fourth update on the Iranian national registry of primary immunodeficiencies: integration of molecular diagnosis. J Clin Immunol. (2018) 38:816–32. 10.1007/s10875-018-0556-1 - DOI - PubMed
  27.  
    1. Al-Herz W, Moussa M. Survival and predictors of death among primary immunodeficient patients: a registry-based study. J Clin Immunol. (2012) 32:467–73. 10.1007/s10875-011-9636-1 - DOI - PubMed
  28.  
    1. Al-Herz W, Nanda A. Skin manifestations in primary immunodeficient children. Pediatr Dermatol. (2011) 28:494–501. 10.1111/j.1525-1470.2011.01409.x - DOI - PubMed
  29.  
    1. Al-Herz W, Essa S. Spectrum of viral infections among primary immunodeficient children: report from a national registry. Front Immunol. (2019) 10:1231. 10.3389/fimmu.2019.01231 - DOI - PMC - PubMed
  30.  
    1. Owayed A, Al-Herz W. Sinopulmonary complications in subjects with primary immunodeficiency. Respir Care. (2016) 61:1067–72. 10.4187/respcare.04479 - DOI - PubMed
  31.  
    1. Delmonte OM, Notarangelo LD. Targeted therapy with biologicals and small molecules in primary immunodeficiencies. Med Princ Pract. (2020) 29:101–12. 10.1159/000503997 - DOI - PMC - PubMed
  32.  
    1. Marrella V, Maina V, Villa A. Omenn syndrome does not live by V(D)J recombination alone. Curr Opin Allergy Clin Immunol. (2011) 11:525–31. 10.1097/ACI.0b013e32834c311a - DOI - PubMed
  33.  
    1. Cassani B, Poliani P, Moratto D, Sobacchi C, Marrella V, Imperatori L, et al. . Defect of regulatory T cells in patients with Omenn syndrome. J Allergy Clin Immunol. (2010) 125:209–16. 10.1016/j.jaci.2009.10.023 - DOI - PubMed
  34.  
    1. Humblet-Baron S, Sather B, Anover S, Becker-Herman S, Kasprowicz DJ, Khim S, et al. . Wiskott-Aldrich syndrome protein is required for regulatory T cell homeostasis. J. Clin. Invest. (2007) 117:407–18. 10.1172/JCI29539 - DOI - PMC - PubMed
  35.  
    1. Cohen A, Nadeau K, Tu W, Hwa V, Dionis K, Bezrodnik L, et al. . Cutting edge: decreased accumulation and regulatory function of CD4CD25(high) T cells in human STAT5b deficiency. J Immunol. (2006) 177:2770–4. 10.4049/jimmunol.177.5.2770 - DOI - PubMed
  36.  
    1. Bussone G, Mouthon L. Autoimmune manifestations in primary immune deficiencies. Autoimmun Rev. (2009) 332–6. 10.1016/j.autrev.2008.11.004 - DOI - PubMed
  37.  
    1. Seidel M. Autoimmune and other cytopenias in primary immunodeficiencies: pathomechanisms, novel differential diagnoses, and treatment. Blood. (2014) 124:2337–44. 10.1182/blood-2014-06-583260 - DOI - PMC - PubMed
  38.  
    1. Hadjadj J, Aladjidi N, Fernandes H, Leverger G, Magérus-Chatinet A, Mazerolles F, et al. . Pediatric evans syndrome is associated with a high frequency of potentially damaging variants in immune genes. Blood. (2019) 134:9–21. 10.1182/blood-2018-11-887141 - DOI - PubMed
  39.  
    1. Notarangelo L. Primary immunodeficiencies (PIDs) presenting with cytopenias. Hematology Am Soc Hematol Educ Program. (2009) 2009:139–43. 10.1182/asheducation-2009.1.139 - DOI - PubMed
  40.  
    1. Tesch VK, Abolhassani H, Shadur B, Zobel J, Mareika Y, Sharapova S, et al. . Long-term outcome of LRBA deficiency in 76 patients after various treatment modalities as evaluated by the immune deficiency and dysregulation activity (IDDA) score. J Allergy Clin Immunol. (2019) 145:1452–63. 10.1016/j.jaci.2019.12.896 - DOI - PubMed

Page Navigation